vs
GEE Group Inc.（JOB）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是GEE Group Inc.的1.7倍（$35.5M vs $20.5M），GEE Group Inc.净利率更高（-0.7% vs -304.2%，领先303.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -21.2%），GEE Group Inc.自由现金流更多（$-1.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -10.5%）
GEE Group Inc.是总部位于美国的专业人力资源解决方案提供商，提供临时用工、合同工安置及永久岗位招聘服务，覆盖信息技术、医疗、财会、法律、轻工制造等核心领域，服务北美市场各规模的客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
JOB vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.7倍
$20.5M
营收增速更快
RXRX
高出702.9%
-21.2%
净利率更高
JOB
高出303.5%
-304.2%
自由现金流更多
JOB
多$46.1M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-10.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.5M | $35.5M |
| 净利润 | $-150.0K | $-108.1M |
| 毛利率 | 36.1% | 59.8% |
| 营业利润率 | -2.0% | -304.8% |
| 净利率 | -0.7% | -304.2% |
| 营收同比 | -21.2% | 681.7% |
| 净利润同比 | 78.3% | 39.6% |
| 每股收益（稀释后） | $0.00 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JOBRXRX
| Q4 25 | $20.5M | $35.5M | ||
| Q3 25 | $23.5M | $5.2M | ||
| Q2 25 | $24.5M | $19.2M | ||
| Q1 25 | $24.5M | $14.7M | ||
| Q4 24 | $24.0M | $4.5M | ||
| Q3 24 | $23.7M | $26.1M | ||
| Q2 24 | $27.0M | $14.4M | ||
| Q1 24 | $25.6M | $13.8M |
净利润JOBRXRX
| Q4 25 | $-150.0K | $-108.1M | ||
| Q3 25 | $-513.0K | $-162.3M | ||
| Q2 25 | $-423.0K | $-171.9M | ||
| Q1 25 | $-33.1M | $-202.5M | ||
| Q4 24 | $-692.0K | $-178.9M | ||
| Q3 24 | $-2.3M | $-95.8M | ||
| Q2 24 | $-19.3M | $-97.5M | ||
| Q1 24 | $-1.0M | $-91.4M |
毛利率JOBRXRX
| Q4 25 | 36.1% | 59.8% | ||
| Q3 25 | 35.8% | -183.8% | ||
| Q2 25 | 35.4% | -4.9% | ||
| Q1 25 | 34.1% | -48.0% | ||
| Q4 24 | 33.0% | -181.4% | ||
| Q3 24 | 37.1% | 53.7% | ||
| Q2 24 | 34.1% | 36.2% | ||
| Q1 24 | 32.8% | 19.1% |
营业利润率JOBRXRX
| Q4 25 | -2.0% | -304.8% | ||
| Q3 25 | -3.3% | -3327.6% | ||
| Q2 25 | -2.2% | -916.8% | ||
| Q1 25 | -94.8% | -1297.9% | ||
| Q4 24 | -3.2% | -4042.4% | ||
| Q3 24 | -5.8% | -377.1% | ||
| Q2 24 | -76.6% | -697.4% | ||
| Q1 24 | -7.6% | -698.4% |
净利率JOBRXRX
| Q4 25 | -0.7% | -304.2% | ||
| Q3 25 | -2.2% | -3135.3% | ||
| Q2 25 | -1.7% | -894.2% | ||
| Q1 25 | -135.2% | -1373.3% | ||
| Q4 24 | -2.9% | -3935.5% | ||
| Q3 24 | -9.5% | -367.5% | ||
| Q2 24 | -71.3% | -676.6% | ||
| Q1 24 | -3.9% | -662.4% |
每股收益（稀释后）JOBRXRX
| Q4 25 | $0.00 | $-0.17 | ||
| Q3 25 | $-0.01 | $-0.36 | ||
| Q2 25 | $0.00 | $-0.41 | ||
| Q1 25 | $-0.30 | $-0.50 | ||
| Q4 24 | $-0.01 | $-0.56 | ||
| Q3 24 | $-0.02 | $-0.34 | ||
| Q2 24 | $-0.18 | $-0.40 | ||
| Q1 24 | $-0.01 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $50.0M | $1.1B |
| 总资产 | $58.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资JOBRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务JOBRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益JOBRXRX
| Q4 25 | $50.0M | $1.1B | ||
| Q3 25 | $50.0M | $1.0B | ||
| Q2 25 | $50.4M | $919.1M | ||
| Q1 25 | $50.6M | $933.9M | ||
| Q4 24 | $83.6M | $1.0B | ||
| Q3 24 | $84.2M | $524.6M | ||
| Q2 24 | $86.3M | $584.4M | ||
| Q1 24 | $105.5M | $401.2M |
总资产JOBRXRX
| Q4 25 | $58.9M | $1.5B | ||
| Q3 25 | $60.0M | $1.4B | ||
| Q2 25 | $60.6M | $1.3B | ||
| Q1 25 | $61.8M | $1.3B | ||
| Q4 24 | $92.8M | $1.4B | ||
| Q3 24 | $95.9M | $726.5M | ||
| Q2 24 | $96.9M | $775.9M | ||
| Q1 24 | $117.0M | $557.8M |
负债/权益比JOBRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | -5.8% | -133.1% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流JOBRXRX
| Q4 25 | $-1.2M | $-46.1M | ||
| Q3 25 | $2.4M | $-117.4M | ||
| Q2 25 | $-743.0K | $-76.4M | ||
| Q1 25 | $-24.0K | $-132.0M | ||
| Q4 24 | $-1.1M | $-115.4M | ||
| Q3 24 | $1.3M | $-59.2M | ||
| Q2 24 | $-1.5M | $-82.2M | ||
| Q1 24 | $1.3M | $-102.3M |
自由现金流JOBRXRX
| Q4 25 | $-1.2M | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | $-755.0K | $-79.6M | ||
| Q1 25 | $-27.0K | $-133.8M | ||
| Q4 24 | $-1.1M | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | $-1.6M | $-83.4M | ||
| Q1 24 | $1.3M | $-109.0M |
自由现金流率JOBRXRX
| Q4 25 | -5.8% | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | -3.1% | -413.9% | ||
| Q1 25 | -0.1% | -907.4% | ||
| Q4 24 | -4.7% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | -5.8% | -578.5% | ||
| Q1 24 | 5.2% | -789.9% |
资本支出强度JOBRXRX
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | 0.0% | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.1% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
